Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
211.8 USD | -0.94% | -4.61% | -10.57% |
12:20pm | Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270 | MT |
06-07 | The job report just threw a spanner in the works |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.57% | 11.02B | |
+46.75% | 56.61B | |
-7.53% | 39.62B | |
+36.02% | 39.25B | |
-9.38% | 28.28B | |
+11.31% | 26.44B | |
-16.98% | 20.12B | |
+30.08% | 12.51B | |
+27.88% | 12.48B | |
-0.80% | 12.2B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Transcript : Charles River Laboratories International, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10